Literature DB >> 21278396

Risk of sports: do we need a pre-participation screening for competitive and leisure athletes?

Domenico Corrado1, Christian Schmied, Cristina Basso, Mats Borjesson, Maurizio Schiavon, Antonio Pelliccia, Luc Vanhees, Gaetano Thiene.   

Abstract

Sudden cardiac arrest is most often the first clinical manifestation of an underlying cardiovascular disease and usually occurs in previously asymptomatic athletes. The risk benefit ratio of physical exercise differs between young competitive athletes and middle-age/senior individuals engaged in leisure-time sports activity. Competitive sports are associated with an increase in the risk of sudden cardiovascular death (SCD) in susceptible adolescents and young adults with underlying cardiovascular disorders. In middle-age/older individuals, physical activity can be regarded as a 'two-edged sword': vigorous exertion increases the incidence of acute coronary events in those who did not exercise regularly, whereas habitual physical activity reduces the overall risk of myocardial infarction and SCD. Although cardiovascular pre-participation evaluation offers the potential to identify athletes with life-threatening cardiovascular abnormalities before onset of symptoms and may reduce their risk of SCD, there is a significant debate among cardiologists about efficacy, impact of false-positive results and cost-effectiveness of routine screening. This review presents an appraisal of the available data and criticisms concerning screening programmes aimed to prevent SCD of either young competitive athletes or older individuals engaged in leisure-time sports activity.

Entities:  

Mesh:

Year:  2011        PMID: 21278396     DOI: 10.1093/eurheartj/ehq482

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  28 in total

Review 1.  Athlete's Heart: Diagnostic Challenges and Future Perspectives.

Authors:  Carlo De Innocentiis; Fabrizio Ricci; Mohammed Y Khanji; Nay Aung; Claudio Tana; Elvira Verrengia; Steffen E Petersen; Sabina Gallina
Journal:  Sports Med       Date:  2018-11       Impact factor: 11.136

2.  Prescribing exercise for women.

Authors:  Carlin Senter; Nicole Appelle; Sarina K Behera
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

Review 3.  Utility of Exercise Electrocardiography in Pre-participation Screening in Asymptomatic Athletes: A Systematic Review.

Authors:  Danny A J P van de Sande; Michelle A W Breuer; Hareld M C Kemps
Journal:  Sports Med       Date:  2016-08       Impact factor: 11.136

Review 4.  Abnormal ECG Findings in Athletes: Clinical Evaluation and Considerations.

Authors:  Mark Abela; Sanjay Sharma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-12-21

5.  Health-risk behaviors among high school athletes and preventive services provided during sports physicals.

Authors:  Karen E Johnson; Annie-Laurie McRee
Journal:  J Pediatr Health Care       Date:  2014-07-17       Impact factor: 1.812

6.  [Sudden cardiac death in athletes and its prevention].

Authors:  T Tönnis; C Tack; K-H Kuck
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 7.  Gelsolin superfamily proteins: key regulators of cellular functions.

Authors:  P Silacci; L Mazzolai; C Gauci; N Stergiopulos; H L Yin; D Hayoz
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

8.  [ECG diagnostics in competitive athletes. Current implications for preparticipation screening].

Authors:  A Preßler; M Halle
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

9.  A Hidden Threat: Anomalous Aortic Origins of the Coronary Arteries in Athletes.

Authors:  Jason Tso; Casey G Turner; Jonathan H Kim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2020-11-07

10.  Physiological rules for the heart, lungs and other pressure-based organs.

Authors:  Aaron R Casha; Liberato Camilleri; Alexander Manché; Ruben Gatt; Marilyn Gauci; Marie-Therese Camilleri-Podesta; Joseph N Grima; Marco Scarci; Stanley Chetcuti
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.